Abstract
The major risk factor of postmenopausal osteoporosis is estrogen deficiency. Hormone replacement therapy is efficacious against osteoporosis, but it induces several significant adverse effects. In this study, therefore, we compared therapeutic potencies of three phytoestrogens: genistein, daidzein, and formononetin. Our result showed that in Saos-2 cells, formononetin and genistein (5 × 10−7 M) treatment increased alkaline phosphatase activity by 33.0 ± 5.8% and 21.1 ± 4.0%. Genistein inhibited osteoclast formation in a dose-dependent manner. In OVX rats, formononetin-treated groups given 1 and 10 mg/kg/day displayed increased trabecular bone areas (TBAs) within the tibia. Genistein- and daidzein-treated groups also displayed increased tibial TBAs. TBAs of the lumbar vertebrae were higher in all treated groups than in the control group. In conclusion, formononetin as well as other isoflavones, such as daidzein and genistein, inhibited bone loss caused by estrogen-deficiency.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bingham, S. A., Atkinson, C., Liggins, J., Bluck, A., and Coward, A., Phytoestrogens: where are we now? Brit. J. Nutr., 79, 393–406 (1998).
Bryant, H. U. and Dere, W. H., Selective estrogen receptor modulators: an alternative to hormone replacement therapy. Proc. Soc. Exp. Biol. Med., 217, 45–52 (1998).
Cassidy, A., Potential tissue selectivity of dietary phytoestrogens and estrogens. Curr. Opin. Lipidol., 10, 47–52 (1999).
Consensus Conference., Osteoporosis. JAMA 252, 799–802 (1984).
Fanti, P., Monier-Faugere, M. C., Geng, Z., Schmidt, J., Morris, P. E., Cohen, D., and Malluche, H. H., The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos. Int., 8, 274–281 (1998).
Ha, H., Lee, Y. S., Lee, J. H., Choi, H., and Kim, C., High performance liquid chromatographic analysis of isoflavones in medicinal herbs. Arch. Pharm. Res., 29, 96–101 (2006).
Ishimi, Y., Miyaura, C., Ohmura, M., Onoe, Y., Sato, T., Uchiyama, Y., Ito, M., Wang, X., Suda, T., and Ikegami, S., Selective effects of genistein,a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology, 140, 1893–1900 (1999).
Jonsson, D., Andersson, G., Ekblad, E., Liang, M., Bratthall, G., and Nilsson, B. OImmunocytochemical demonstration of estrogen receptor beta in human periodontal ligament cells. Arch. Oral Biol., 49, 85–88 (2004).
Kassem, M., Mosekilde, L., and Eriksen, E. F., 1,25-Dihydroxyvitamin D3 protentiates fluoride-stimulated collagen type oduction in cultures of human bone marrow stromal osteoblast-like cells. J. Bone Miner. Res., 8, 1453–1458 (1993).
Kim, C., Kim, J. S., Kim, Y. T., and Song, K. Y., Effects of herbal medicine on tibia bone changes in ovariectomized rats and SAM P6 mice. Yakhakhoe Chi, 42, 220–228(1998).
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., Van Der Saag, P. T., Van Der Burg, B., and Gustafsson, J. A., Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology, 139, 4252–4263 (1998).
Lark, M. W., Stroup, G. B., Dodds, R. A., Kapadia, R., Hoffman, S. J., Hwang, S. M., James, I. E., Lechowska, B., Liang, X., Rieman, D. J., Salyers, K. L., Ward, K., Smith, B. R., Miller, W. H., Huffman, W. F., and Gowen. M., Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat. J. Bone Miner. Res., 16, 319–327 (2001).
Markiewicz, L., Garey, J., Adlercreutz, H., and Gurpide, E., In vitro bioassay of non-steroidal phytoestrogens. J. Steroid Biochem. Mol. Biol., 45, 399–405 (1993).
Nordin, B. E., Heyburn, P. J., and Peacock, M., Osteoporosis and osteomalacia. Clin. Endocrinol. Metab., 9, 177–205 (1980).
Parkar, M. H., Newman, H. N., and Olsen, I., Polymerase chain reaction analysis of oestrogen and androgen receptor expression in human gingival and periodontal tissue. Arch. Oral Biol., 41, 979–983 (1996).
Ragab, A. A., Lanvish, S. A., Banks, M., Goldgerg, V. M., and Greenfiled, E. M., Osteocalst differentiation requires ascorbic acid. J. Bone Miner. Res., 13, 970–977 (1998).
Ryu, S. Y., Lee, H. S., Kim, Y. K. and Kim, S. H., Determination of isoprenyl and lavandulyl positions of flavonoids from Sophora flavescens. Arch. Pharm. Res., 20, 491–495 (1997).
Sabokbar, A., Millett, P. J., Myer, B., and Rushton, N., A rapid, quantitative assay for measuring alkaline phosphatase activity in osteoblastic cells in vitro. Bone Miner., 27, 57–67 (1994).
Saloniemi, H., Wahala, K., Nykanen-Kurki, P., Kallela, K., and Saastamoinen, I., Phytoestrogen content and estrogenic effect of legume fodder. Proc. Soc. Exp. Biol. Med., 208, 13–17 (1995).
Shioi, A., Ross, P., and Teitelbaum, S. L., Enrichiment of generated Murin Osteoclasts. Calcif. Tissue Int., 55, 387–394 (1994).
Shutt, D. A., The effectsof plant oestrogens on animal reproduction. Endeavour, 35, 110–113 (1976).
Spencer, H., Rubio, N., Rubio, E., Indreika, M., and Seitam, A., Chronic alcoholism: Frequently overlooked cause of osteoporosis in men. Am. J. Med., 80, 393–397 (1986).
Wang, W., Tanaka, Y., Han, E., and Higuchi, C. M., Proliferative response of mammary glandular tissue to formononetin. Nutr. Cancer, 23, 131–140 (1995).
Yoon, H. K., Chen, K., Baylink, D. J., and Lau, K. H. W., Differential effects of two protein tyrosine kinase inhibitors, tyrphostin and genistein, on human bone cell proliferation as compared with differentiation. Calcif. Tissue Int., 63, 243–249 (1998).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ha, H., Lee, H.Y., Lee, JH. et al. Formononetin prevents ovariectomy-induced bone loss in rats. Arch. Pharm. Res. 33, 625–632 (2010). https://doi.org/10.1007/s12272-010-0418-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-0418-8